Randall J. Bateman, MD, the Charles F. and Joanne Knight Distinguished Professor of Neurology at WashU Medicine, is the study director of an international clinical trial that finds an anti-amyloid drug can delay the onset of cognitive decline if given many years before symptoms of Alzheimer’s disease arise. The participants in the study had inherited genetic variants that lead to early-onset Alzheimer’s disease, and…